Quantbot Technologies LP Buys Shares of 36,631 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Quantbot Technologies LP purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 36,631 shares of the exchange traded fund’s stock, valued at approximately $3,619,000.

Other hedge funds have also made changes to their positions in the company. Hartline Investment Corp raised its holdings in SPDR S&P Biotech ETF by 2.0% in the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock valued at $544,000 after acquiring an additional 106 shares in the last quarter. Intellectus Partners LLC lifted its position in shares of SPDR S&P Biotech ETF by 1.0% during the 2nd quarter. Intellectus Partners LLC now owns 11,334 shares of the exchange traded fund’s stock worth $1,051,000 after purchasing an additional 113 shares during the last quarter. Signature Estate & Investment Advisors LLC grew its stake in shares of SPDR S&P Biotech ETF by 5.7% during the third quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after purchasing an additional 125 shares in the last quarter. Denver Wealth Management Inc. increased its holdings in SPDR S&P Biotech ETF by 0.9% in the third quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock valued at $1,460,000 after buying an additional 127 shares during the last quarter. Finally, Bourgeon Capital Management LLC raised its stake in SPDR S&P Biotech ETF by 5.9% in the second quarter. Bourgeon Capital Management LLC now owns 2,427 shares of the exchange traded fund’s stock valued at $225,000 after buying an additional 135 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $100.00 on Thursday. SPDR S&P Biotech ETF has a 1 year low of $72.10 and a 1 year high of $105.47. The company has a market capitalization of $7.62 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The business has a 50-day moving average of $98.33 and a two-hundred day moving average of $96.46.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.